Leading Japanese Regenerative Medicine & Drug Discovery Venture Companies

Presentations
Leading Japanese Regenerative Medicine & Drug Discovery Venture Companies
KENICHI AKAMATSU
CEO, President Megakaryon Corporation
MASAYA MATSUMOTO
President and CEO TWOCELLS company limited
KEIICHI FUKUDA
Founding Scientist and CEO Heartseed
KENJI NONAKA
M.D., Ph.D. President, Representative Director and CEO of Orizuru Therapeutics, Inc.
DANIEL KEMP
CEO Shinobi Therapeutics, Inc.
--------------------
INVESTING IN JAPANESE REGENERATIVE MEDICINE | Nikkei
OVERVIEW
Regenerative Medicine is highly anticipated in Japan from its potential and impact. Many players are participating, among them, venture companies are very active in this field. The event will have insightful discussions, and presentations with government officials, academia and companies focusing on Japanese Regenerative Medicine & Drug Discovery.